Medical comorbidity affects antidepressant treatment response in patients with melancholic depression

Psychotherapy and Psychosomatics

Volumn 78, Issue 6, 2009, Pages 359-363

  Pohle, K ^a   Domschke, K ^a   Roehrs, T ^a   Arolt, V ^a   Baune, B T ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

Medical comorbidity; Subtypes of depression; Treatment response

Indexed keywords

ESCITALOPRAM; MIRTAZAPINE; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL SPECIALIST; MELANCHOLIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT RESPONSE; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; CARDIOVASCULAR DISEASE; CHI SQUARE DISTRIBUTION; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; ENDOCRINE DISEASE; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES;

EID: 76849101804     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235975     Document Type: Article

References (14)

1. Katon WJ: Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003;54:3:216-226.
2. Baune BT, Adrian I, Jacobi F: Medical disorders affect health outcome and general functioning depending on comorbid major depression in the general population. J Psychosom Res 2007;62:2:109-118. (Pubitemid 46161593)
3. Baune BT, Adrian I, Arolt V, Berger K: Associations between major depression, bipolar disorders, dysthymia and cardiovascular diseases in the general adult population. Psychother Psychosom 2006;75:5:319-326. (Pubitemid 44200480)
4. Katz IR, Striem J, Parmelee P: Psychiatric-medical comorbidity: implications for health services delivery and for research on depression. Biol Psychiatry 1994;36:3:141-145.
5. Bogner HR, Cary MS, Bruce ML, Reynolds CF 3rd, Mulsant B, Ten Have T, Alexopoulos GS: The role of medical comorbidity in outcome of major depression in primary care: the PROSPECT study. Am J Geriatr Psychiatry 2005;13:10:861-868.
6. Perlis RH, Iosifescu DV, Alpert J, Nierenberg AA, Rosenbaum JF, Fava M: Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression. Psychosomatics 2004;45:3:224-229. (Pubitemid 38621531)
7. Oslin DW, Datto CJ, Kallan MJ, Katz IR, Edell WS, TenHave T: Association between medical comorbidity and treatment outcomes in late-life depression. J Am Geriatr Soc 2002;50:5:823-828. (Pubitemid 34496677)
8. Taylor WD, McQuoid DR, Krishnan KR: Medical comorbidity in late-life depression. Int J Geriatr Psychiatry 2004;19:10:935-943.
9. Rush AJ: The varied clinical presentations of major depressive disorder. J Clin Psychiatry 2007;68(suppl 8):4-10. (Pubitemid 47184565)
10. Melartin T, Leskela U, Rytsala H, Sokero P, Lestela-Mielonen P, Isometsa E: Co-morbidity and stability of melancholic features in DSM-IV major depressive disorder. Psychol Med 2004;34:8:1443-1452. (Pubitemid 39599942)
11. Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M: SCID: Clinical Interview for DSM-IV (German version). Goettinge, Hogrefe - Verlag für Psychologie, 1997.
12. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
13. Sheehan DV: MOS Psychiatric Evaluation. Past Medical History and Current Health Practices. Jacksonville, Medical Outcome Systems, 2006.
14. Baune BT, Hohoff C, Berger K, Neumann A, Mortensen S, Roehrs T, Deckert J, Arolt V, Domschke K: Association of the COMT val-158met variant with antidepressant treatment response in major depression. Neuropsychopharmacology 2008;33:4:924-932. (Pubitemid 351252697)